Skip to main content

and
  1. No Access

    Article

    Structure and Photocatalytic Properties of a 3D Zinc(II) Triazolate Coordination Polymer Combining Hydroxyl and Formate Anions as the Auxiliary Coligands

    A new 3D zinc coordination polymer, namely {[Zn4(dmtz)3(OH)3(HCOO)](NO3)}n (1, Hdmtz = 3,5- dimethyl-1,2,4-triazole), is hydrothermally synthesized and structurally characterized by elemental analyses, IR spectro...

    X.-D. Fang, L.-B. Yang, A.-N. Dou, A.-X. Zhu, Q.-Q. Xu in Journal of Structural Chemistry (2018)

  2. Article

    Open Access

    Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer

    Current data suggest that platinum-based combination therapy is the standard first-line treatment for biliary tract cancer. EGFR inhibition has proven beneficial across a number of gastrointestinal malignancie...

    A F Hezel, M S Noel, J N Allen, T A Abrams, M Yurgelun in British Journal of Cancer (2014)

  3. Article

    Open Access

    Sunitinib in combination with gemcitabine for advanced solid tumours: a phase I dose-finding study

    This phase I, dose-finding study determined the maximum tolerated dose (MTD), safety, and pharmacokinetics of sunitinib plus gemcitabine in patients with advanced solid tumours.

    M D Michaelson, A X Zhu, D P Ryan, D F McDermott, G I Shapiro in British Journal of Cancer (2013)

  4. No Access

    Article

    The role of signaling pathways in the development and treatment of hepatocellular carcinoma

    Hepatocellular carcinoma (HCC) is a highly prevalent, treatment-resistant malignancy with a multifaceted molecular pathogenesis. Current evidence indicates that during hepatocarcinogenesis, two main pathogenic...

    S Whittaker, R Marais, A X Zhu in Oncogene (2010)

  5. No Access

    Article

    Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors

    MAC-321 is a novel taxane that has demonstrated exceptional activity in human xenograft models when administered intravenously and orally. Preclinical studies of MAC-321 have shown antitumor activity in MDR-ex...

    A. C. Lockhart, R. Bukowski, M. L. Rothenberg in Cancer Chemotherapy and Pharmacology (2007)